Summit Therapeutics Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-20 17:35:56 ET
More on Summit Therapeutics
- Summit Therapeutics: PDUFA Coming, But Is It Good Enough? (Rating Upgrade)
- Summit Therapeutics Inc. (SMMT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Summit Therapeutics Inc. (SMMT) Presents at Evercore 8th Annual Healthcare Conference Transcript
- Summit spikes as lead asset undergoes FDA review
- Seeking Alpha’s Quant Rating on Summit Therapeutics
Read the full article on Seeking Alpha
For further details see:
Summit Therapeutics Q4 2025 Earnings Preview
Summit Therapeutics Inc.
NASDAQ: SMMT
SMMT Trading
1.73% G/L:
$15.03 Last:
875,376 Volume:
$14.73 Open:
SMMT Latest News
SMMT Stock Data
$11,408,581,895
112,410,823
0.02%
74
N/A
Biotechnology & Life Sciences
Healthcare
US
Miami
